Journal rankings · indicator year 2003
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2003
Immunology journal rankings 2003
65 ranked journals · Subfield in Immunology and Microbiology
Immunology has 65 ranked journals in 2003. The median journal has an OJR of 0.82, below the world average of 1.00, down 0.01 on 2002; Q1 starts at OJR 1.21. The top three are Immunity, Nature Immunology, and The Journal of Experimental Medicine.
Ranks and citation indicators: 2003. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2000–2002, the window the 2003 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Immunology and Microbiology (5)
65 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2002. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2000–2002, the window the 2003 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2000–2002 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2003. | Compare |
|---|---|---|---|---|---|---|---|
1ImmunityCell Press · United States | 5.64Q1 | 17.40 1.12 down from 2002 | 473 | 100% | $10,400 | ||
2Nature ImmunologyNature Portfolio · United States | 5.32Q1 | 16.52 0.37 up from 2002 | 633 | 11% | $12,690 | ||
3The Journal of Experimental MedicineRockefeller University Press · United States | 5.18Q1 | 15.80no change | 1,067 | 100% | — | ||
4Annual Review of ImmunologyAnnual Reviews · United States | 3.59Q1 | 56.35 2.69 down from 2002 | 83 | 0% | — | ||
5Immunology TodayElsevier BV · United Kingdom | 2.41Q1 | —no 2002 value | 192 | — | — | ||
6The Journal of ImmunologyAmerican Association of Immunologists · United States | 2.29Q1 | 7.47 0.03 up from 2002 | 5,250 | 50% | $3,500 | ||
7Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 2.21Q1 | 6.56 0.60 up from 2002 | 1,205 | 40% | $4,900 | ||
8Seminars in ImmunologyElsevier BV · United States | 2.06Q1 | 5.17 2.35 down from 2002 | 174 | 9% | $4,370 | ||
9ImmunopharmacologyElsevier BV · Netherlands | 1.54Q1 | —no 2002 value | 114 | — | — | ||
10Journal of Leukocyte BiologyOxford University Press · United States | 1.48Q1 | 4.40 0.25 up from 2002 | 759 | 11% | $3,800 | ||
11Critical Reviews in ImmunologyBegell House · United States | 1.47Q1 | 3.47 0.47 up from 2002 | 76 | 5% | — | ||
12Nature reviews. ImmunologyNature Portfolio · United Kingdom | 1.39Q1 | 9.52 4.49 up from 2002 | 311 | 5% | — | ||
13European Journal of ImmunologyWiley · Germany | 1.39Q1 | 4.42 0.16 up from 2002 | 1,477 | 60% | $4,550 | ||
14Genes and ImmunitySpringer Nature · United States | 1.38Q1 | 4.13 1.02 up from 2002 | 213 | 8% | $3,190 | ||
15Journal of AutoimmunityElsevier BV · United Kingdom | 1.30Q1 | 2.66 0.71 down from 2002 | 267 | 3% | $5,420 | ||
16Journal of Reproductive ImmunologyElsevier BV · Netherlands | 1.26Q1 | 3.09 0.66 up from 2002 | 164 | 0% | $3,690 | ||
17International ImmunologyOxford University Press · United Kingdom | 1.21Q1 | 3.88 0.16 up from 2002 | 505 | 22% | $3,530 | ||
18Journal of Immunological MethodsElsevier BV · Netherlands | 1.19Q2 | 3.06 0.30 up from 2002 | 733 | 3% | $2,970 | ||
19Immunological ReviewsWiley · United States | 1.14Q2 | 7.91 0.48 up from 2002 | 288 | 5% | $5,000 | ||
20International Reviews of ImmunologyTaylor & Francis · United States | 1.12Q2 | 2.55 0.19 up from 2002 | 100 | 0% | — | ||
21Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.10Q2 | 2.55 0.02 down from 2002 | 165 | 2% | $4,990 | ||
22Expert Opinion on Biological TherapyTaylor & Francis · United Kingdom | 1.05Q2 | 2.71 0.62 up from 2002 | 172 | 5% | — | ||
23Clinical ImmunologyElsevier BV · Netherlands | 1.05Q2 | 3.04 0.28 up from 2002 | 453 | 2% | $4,400 | ||
24Immunology and Cell BiologyWiley · Australia | 1.05Q2 | 2.82 0.47 up from 2002 | 254 | 13% | $3,750 | ||
25Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.03Q2 | 2.49 0.04 up from 2002 | 929 | 96% | $3,816 | ||
26Molecular ImmunologyElsevier BV · Netherlands | 1.00Q2 | 3.14 0.95 up from 2002 | 334 | 1% | $3,340 | ||
27ImmunologyWiley · United Kingdom | 0.97Q2 | 2.84 0.22 up from 2002 | 629 | 36% | $5,330 | ||
28Developmental & Comparative ImmunologyElsevier BV · United Kingdom | 0.97Q2 | 3.10 0.94 up from 2002 | 230 | 9% | $3,340 | ||
29Immunologic ResearchSpringer Science+Business Media · United States | 0.93Q2 | 2.41 0.14 down from 2002 | 164 | 2% | $2,890 | ||
30CytokineElsevier BV · United Kingdom | 0.91Q2 | 2.50 0.08 up from 2002 | 624 | 1% | $3,220 | ||
31ImmunogeneticsSpringer Science+Business Media · Germany | 0.87Q2 | 3.14 0.75 up from 2002 | 374 | 7% | $2,890 | ||
32Journal of Interferon & Cytokine ResearchMary Ann Liebert, Inc. · United States | 0.85Q2 | 2.29 0.43 up from 2002 | 414 | 7% | — | ||
33Human ImmunologyElsevier BV · United States | 0.82Q2 | 2.53 0.09 down from 2002 | 518 | 1% | $3,600 | ||
34BioDrugsAdis, Springer Healthcare · Switzerland | 0.80Q3 | 2.65 1.31 up from 2002 | 194 | 0% | $5,190 | ||
35Springer Seminars in ImmunopathologySpringer Science+Business Media · Germany | 0.79Q3 | 1.02 1.14 down from 2002 | 93 | 3% | — | ||
36Current Opinion in ImmunologyElsevier BV · United Kingdom | 0.79Q3 | 11.23 0.40 down from 2002 | 342 | 1% | $4,410 | ||
37Veterinary Immunology and ImmunopathologyElsevier BV · Netherlands | 0.76Q3 | 1.89 0.23 up from 2002 | 479 | 5% | $3,250 | ||
38Trends in ImmunologyElsevier BV · United Kingdom | 0.75Q3 | 5.69 1.10 up from 2002 | 491 | 6% | $7,030 | ||
39Cytokine & Growth Factor ReviewsElsevier BV · United Kingdom | 0.74Q3 | 7.99 1.57 down from 2002 | 122 | 2% | $4,900 | ||
40Cellular ImmunologyElsevier BV · Netherlands | 0.70Q3 | 1.78 0.22 down from 2002 | 377 | 3% | $3,550 | ||
41Scandinavian Journal of ImmunologyWiley · United Kingdom | 0.67Q3 | 1.99 0.26 up from 2002 | 522 | 57% | $4,480 | ||
42Immunology LettersElsevier BV · Netherlands | 0.65Q3 | 1.83 0.08 up from 2002 | 458 | 4% | $3,290 | ||
43Toxicologic PathologySAGE Publishing · United States | 0.65Q3 | 1.48 0.10 down from 2002 | 335 | 24% | $4,150 | ||
44Fish & Shellfish ImmunologyElsevier BV · United Kingdom | 0.64Q3 | 2.62 0.90 up from 2002 | 195 | 4% | $4,330 | ||
45International Journal of ImmunopharmacologyElsevier BV · United Kingdom | 0.64Q3 | —no 2002 value | 104 | — | — | ||
46International Journal of Clinical & Laboratory ResearchSpringer Science+Business Media · Germany | 0.61Q3 | —no 2002 value | 36 | — | — | ||
47Experimental and Clinical ImmunogeneticsKarger Publishers · Switzerland | 0.61Q3 | 1.70 0.06 up from 2002 | 50 | — | — | ||
48Inflammation ResearchSpringer Science+Business Media · Switzerland | 0.59Q3 | 1.56 0.03 down from 2002 | 424 | 2% | $4,790 | ||
49American Journal of Reproductive ImmunologyWiley · United Kingdom | 0.51Q3 | 1.67 0.49 up from 2002 | 253 | 10% | $4,460 | ||
50Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 0.50Q4 | 1.33 0.54 up from 2002 | 125 | 4% | $5,490 |
Subfields of Immunology and Microbiology, with Immunology highlighted.
Journals
Citations made in 2003. Corpus-wide, 70.2% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
15 additional Immunology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2000–2002, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2003. Publication window: 2000–2002. How these summaries are calculated
- Ranked journals
- 65
- Window papers (baseline)
- 40,362 +19.9% from indicator year 2000
- Median OJR
- 0.82 +14.7% from indicator year 2000
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2000–2002 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 56 | 59 | 63 | 65 | 62 | 64 | 68 | 72 | 71 | 74 | 76 | 79 | 81 | 86 | 83 | 88 | 90 | 96 | 94 | 90 | 92 | 87 | 88 | 88 | 88 | 86 | |
| Window papers (baseline) | 33,673 | 35,811 | 37,963 | 40,362 | 42,065 | 44,849 | 47,600 | 50,960 | 53,923 | 57,726 | 63,072 | 65,596 | 67,601 | 67,579 | 70,684 | 72,624 | 73,354 | 72,790 | 72,098 | 72,447 | 74,045 | 77,362 | 81,615 | 83,779 | 84,353 | 84,391 | |
| Median OJR | 0.72 | 0.78 | 0.834 | 0.82 | 0.830 | 0.88 | 0.89 | 0.959 | 1.002 | 1.15 | 1.100 | 1.09 | 1.096 | 1.04 | 1.08 | 1.06 | 1.05 | 0.95 | 0.921 | 0.970 | 0.931 | 0.932 | 0.967 | 0.956 | 0.922 | 0.87 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.